AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.24%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.98B
AUM Growth
+$3.98B
(-7.4%)
Cap. Flow
-$339M
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
293
New
68
Increased
45
Reduced
98
Closed
73
Top Buys
| 1 |
Pfizer
PFE
|
$76.9M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$59.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$56.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$51.7M |
| 5 |
Keurig Dr Pepper
KDP
|
$42.1M |
Top Sells
| 1 |
GSK
GSK
|
$105M |
| 2 |
Exact Sciences
EXAS
|
$83M |
| 3 |
Organon & Co
OGN
|
$75.3M |
| 4 |
Biogen
BIIB
|
$55.3M |
| 5 |
Central Garden & Pet Class A
CENTA
|
$53.3M |
Sector Composition
| 1 | Healthcare | 68.27% |
| 2 | Consumer Staples | 10.31% |
| 3 | Technology | 7.85% |
| 4 | Consumer Discretionary | 7.66% |
| 5 | Communication Services | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $156M | 2.25% | 1,650,000 +58,000 | +4% | +$5.47M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $151M | 2.19% | 5,036,000 +686,000 | +16% | +$20.6M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $144M | 2.08% | 3,978,000 +286,000 | +8% | +$10.3M |
|
4
PTC Therapeutics
PTCT
$3.92B
| $132M | 1.9% | 3,236,000 +312,000 | +11% | +$12.7M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $114M | 1.66% | 7,450,000 +302,000 | +4% | +$4.64M |
|
6
Incyte
INCY
$16.5B
| $111M | 1.6% | 1,776,000 -96,000 | -5% | -$5.98M |
|
7
Agios Pharmaceuticals
AGIO
$2.19B
| $92.2M | 1.33% | 3,256,000 -204,000 | -6% | -$5.78M |
|
|
8
Regeneron Pharmaceuticals
REGN
$61.5B
| $89.1M | 1.29% | 124,000 +72,000 | +138% | +$51.7M |
|
9
argenx
ARGX
$43.6B
| $77.9M | 1.13% | 200,000 -24,000 | -11% | -$9.35M |
|
|
10
Pfizer
PFE
$141B
| $76.9M | 1.11% | +2,096,000 | New | +$76.9M |
|
11
Johnson & Johnson
JNJ
$427B
| $76.1M | 1.1% | 460,000 +2,117 | +0.5% | +$350K |
|
|
12
Biogen
BIIB
$19.4B
| $72.9M | 1.06% | 256,000 -194,000 | -43% | -$55.3M |
|
13
UnitedHealth
UNH
$281B
| $72.1M | 1.04% | 150,000 -42,000 | -22% | -$20.2M |
|
14
Dentsply Sirona
XRAY
$2.85B
| $72M | 1.04% | 1,800,000 -456,000 | -20% | -$18.2M |
|
15
Freshpet
FRPT
$2.72B
| $69.1M | 1% | 1,050,000 -137,000 | -12% | -$9.02M |
|
16
Amazon
AMZN
$2.44T
| $68.3M | 0.99% | 524,000 -400,000 | -43% | -$52.1M |
|
17
Medtronic
MDT
$119B
| $66.6M | 0.96% | 756,000 +78,000 | +12% | +$6.87M |
|
18
Alphabet (Google) Class A
GOOGL
$2.57T
| $65.6M | 0.95% | 548,000 -252,000 | -32% | -$30.2M |
|
|
DCPH
19
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $64.2M | 0.93% | 4,560,000 +460,000 | +11% | +$6.48M |
|
20
Alkermes
ALKS
$4.78B
| $62.6M | 0.91% | 2,000,000 -724,000 | -27% | -$22.7M |
|
|
NVRO
21
DELISTED
NEVRO CORP.
NVRO
| $59.9M | 0.87% | +2,356,000 | New | +$59.9M |
|
|
22
Jazz Pharmaceuticals
JAZZ
$7.75B
| $56.5M | 0.82% | +456,000 | New | +$56.5M |
|
23
Microsoft
MSFT
$3.77T
| $54.5M | 0.79% | 160,000 -42,676 | -21% | -$14.5M |
|
24
Colgate-Palmolive
CL
$67.9B
| $46.3M | 0.67% | 601,000 -345,000 | -36% | -$26.6M |
|
25
Aurinia Pharmaceuticals
AUPH
$1.58B
| $45.4M | 0.66% | 4,692,000 +520,000 | +12% | +$5.03M |
|